Tiziana Life Sciences is trading 5.5% down at $0.84, with no clear company-specific announcement identified for September 15, 2026.
- Shares closed at $0.89 on September 14, 2026, when they fell 7.27%.
- The company’s latest listed release was an August 24, 2026 clinical-trial poster presentation.
- Broader indexes are modestly lower, but the market decline is not sufficiently strong to establish a macro-driven cause.